achieved sustained virological

Related by string. * achieving . Achieved . Achieving . achiever : achieving gender equality . achieved statistical significance . quiet achiever . achieved CE Marking / sustains . Sustaining . Sustained . sustaining : Maximum sustained winds . Maximum Sustained Winds . self sustaining / Virological : virological response . complete Early Virological . sustained virological response * *

Related by context. Frequent words. (Click for all words.) 67 sustained virologic response 67 evaluable 67 plus dexamethasone 65 mg kg dose 64 virologic failure 64 HCV genotype 1 63 metastatic renal cell carcinoma 63 decitabine 63 cytogenetic response 62 nonresponders 62 peginterferon 62 peginterferon alfa 2a 62 ponatinib 62 mg QD 62 XELOX 62 HCV infected 62 evaluable patients 62 peginterferon alfa 2b 62 virologic response 61 pegylated interferon 61 azacitidine 61 cabazitaxel 61 RECIST criteria 61 Secondary endpoints include 61 gefitinib 61 annualized relapse 61 nilotinib 61 vandetanib 61 PRECiSE 61 relapsed refractory multiple myeloma 60 plus methotrexate 60 coinfected 60 interferon therapy 60 tipranavir 60 Fludara 60 dasatinib 60 T2DM 60 mycophenolate mofetil 60 free survival PFS 60 HBV DNA 60 hepatitis C HCV 60 infliximab 59 Jevtana 59 EGFR mutations 59 chronic hepatitis B. 59 DMARD 59 FOLFIRI 59 statistically significant p = 59 dose cohorts 59 neoadjuvant 59 glatiramer acetate 59 STELARA 59 iclaprim 59 neoadjuvant chemotherapy 59 Taxotere ® 59 sunitinib 59 COPAXONE R 59 plus ribavirin 59 adefovir 59 Amrubicin 59 disease modifying antirheumatic 58 metastatic hormone refractory 58 anti TNF 58 imatinib 58 active comparator 58 nab paclitaxel 58 nitazoxanide 58 chronic HCV infection 58 complete remissions 58 mcg dose 58 abiraterone acetate 58 linezolid 58 seroconversion 58 interferon alfa 58 mg BID 58 plus prednisone 58 undetectable viral load 58 LMWH 58 chemoradiotherapy 58 TNF inhibitors 58 VIDAZA 58 Chronic Hepatitis C 58 NNRTI 58 chronic HCV 58 angiotensin converting enzyme inhibitors 58 peg IFN 58 neoadjuvant therapy 57 CMV disease 57 HER2 positive metastatic breast 57 entecavir 57 placebo p = 57 tumor shrinkage 57 PegIntron 57 breast carcinoma 57 lupus nephritis 57 TREANDA 57 nortriptyline 57 HbA1c levels 57 Erlotinib 57 enalapril 57 raltegravir

Back to home page